期刊文献+

胆汁形成与胆汁淤积性疾病发生的机制 被引量:5

Molecular mechanism of bile formation and cholestatic diseases
原文传递
导出
摘要 胆汁淤积是指在肝细胞水平或胆管水平胆汁生成、分泌或流动障碍。肝细胞与胆管细胞膜上存在众多的蛋白质是胆汁形成与分泌的重要转运体,随着对这些转运体的鉴定,以及对影响胆汁酸盐合成、转运的复杂信号网络系统的深入了解,为充分认识胆汁淤积形成的分子机制提供了重要价值。
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2008年第8期571-573,共3页 Chinese Journal of Hepatology
关键词 胆汁淤积 胆汁淤积性疾病 机制 Cholestasis Cholestatic diseases Mechanism
  • 相关文献

参考文献16

  • 1Zollner G, Trauner M. Mechanisms of cholestasis. Clin Liver Dis, 2008, 12: 1-26, vii.
  • 2Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev, 2003, 83: 633-671.
  • 3Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med, 1998, 339: 1217-1227.
  • 4Arrese M, Trauner M. Molecular aspects of bile formation and cholestasis. Trends Mol Med, 2003, 9: 558-564.
  • 5Zollner G, Fickert P, Zenz R, et al. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology, 2001, 33: 633-646.
  • 6Paulusma CC, Groen A, Kunne C, et al. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology, 2006, 44: 195- 204.
  • 7Noe J, Hagenbuch B, Meier P J, et al. Characterization of the mouse bile salt export pump overexpressed in the baculovirus system. Hepatology, 2001, 33: 1223-1231.
  • 8an Mil SW, van der Woerd WL, van der Brugge G, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB 11. Gastroenterology, 2004, 127: 379-384.
  • 9Paulusma CC, Kool M, Bosma PJ, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology, 1997, 25: 1539-1542.
  • 10Feranchak AP, Sokol RJ. Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis, 2001, 21: 471-488.

同被引文献51

  • 1乔立兴,郑意楠,钱钻好,黄莉,毕明远,李海浪.长期肠外营养与胆汁淤积症相关因素的临床分析[J].肠外与肠内营养,2008,15(1):36-38. 被引量:13
  • 2Schiff ER,Sorrell MF,Maddrey WC. Schiff's diseases of the liver. 10th ed. Philadelphia : Lippincott Williams & Wilkins, 2006:42 - 48.
  • 3Fevery J. Bilirubin in clinical practive: a review. Liver Int, 2008,28 ( 5 ) : 592 - 605.
  • 4Reichling JJ, Kaplan MM. Clinical use of serum enzymes in liver disease. Dig Dis Sci, 1988,33 (12) : 1601 - 1614.
  • 5Sapey T, Mendler MH, Guyader D, et al. Respective value of alkaline phosphatase, gamma - glutamyl transpeptidase and 5 'nucleotidase serum activity in the diagnosis of cholestasis: a prospective study of 80 patients. J Clin Gastroenterol, 2000, 30 (3) :259 - 263.
  • 6Pasanen P, Pikkarainen P, Alhava E,et al. Value of serum alkaline phosphatase, aminotransferases, gamma - glutamyl transferase,leueine aminopeptidase,and bilirubin in the distinetion between benign and malignant diseases causing jaundice and eholestasis: results from a prospective study. Seand J Clin Lab Invest, 1993,53( 1 ) :35 -39.
  • 7金汉珍,黄德珉,官希吉,等.实用新生儿学[M].第3版.北京:人民卫生出版社,2009:838-842.
  • 8Arrese M, Ananthananarayanan M, Suchy FJ. Hepatobiliary transporl: molecular mechanisms of development and cholcstasis [J]. Pcdiatr Res, 1998, 44 ( 2 ) : 141-147.
  • 9Meier P J, Stieger B. Bile salt transporters [J]. Annu Rev Physiol, 2002, 64(4) : 635-661.
  • 10Arrese M, Trauner M. Molecular aspects of bile formation and cholestasis [J]. Trends in Molecular Medicine, 2003, 9 ( 12 ) : 558-564.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部